Cite
HARVARD Citation
Tanaka*, Y. et al. (n.d.). Additive Effect of Inhaled Corticosteroid (ICS) On Patients with COPD Receiving Long-Acting Muscarinic Antagonist (LAMA)/Long-Acting Β2-Agonist (LABA): A Single-Center Observational Study. European journal of respiratory medicine. 2 (1), pp. 137-. [Online].